menu search

TCR² Therapeutics to Present at SVB Securities Global Biopharma Conference 2023

TCR² Therapeutics to Present at SVB Securities Global Biopharma Conference 2023
CAMBRIDGE, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) — TCR² Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage cell therapy company with a pipeline of novel T cell therapies for patients suffering from solid tumors, today announced that management will present a company update at the SVB Securities Global Biopharma Conference (virtual) on Tuesday, February 14, 2023 at 1:00 […] The post TCR² Therapeutics to Present at SVB Securities Global Biopharma Conference 2023 appeared first on ForexTV... Read More
Posted: Feb 8 2023, 11:45
Author Name: forextv
Views: 111518

Search within

Pages Search Results: